Berko Pharmaceuticals, manufacturing with “For Healthy Tomorrows” vision with an innovative perspective, nearly 800 employees and a 21 thousand square meter manufacturing facility consisting of 3 phases of world standards established a new group and expanded its staff.
Continuing to work and produce for health, Berko Pharmaceuticals set up a new group dedicated to internal medicine and expanded its field staff. Being a preferred company with career opportunities, Berko Pharmaceuticals recruited nearly a hundred people for this new group and expanded its organizational structure with internal appointments. In this process, mostly experienced medical representatives, regional managers and product managers were recruited. Berko Pharmaceuticals’ goal for 2020 is to continue recruiting and employment of staff for its Manufacturing Plant and headquarters.
2019 has been a year where Berko Pharmaceuticals has grown with its factory investments, R&D center, new products, export breakthroughs, turnover and new employees. Berko Pharmaceuticals Chairman of the Board Pharm. Berat Beran said, “2019 has been a year in which we continued to grow in all fields. We are especially proud to contribute to the national economy and Turkish medicine, with our new group in internal medicine and the employment of nearly hundred people.”
Berko Pharmaceuticals recently initiated a strategic partnership in the Balkans and signed a contract with Fufarma of Albanian origin. With this new partnership in the Balkans, Berko Pharmaceuticals aims to further strengthen its export activities and establish a common structure that will generate income for Turkey.